Albert Eid

1.4k total citations
20 papers, 969 citations indexed

About

Albert Eid is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Albert Eid has authored 20 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 8 papers in Infectious Diseases and 3 papers in Virology. Recurrent topics in Albert Eid's work include Cytomegalovirus and herpesvirus research (9 papers), Herpesvirus Infections and Treatments (6 papers) and Neurological Complications and Syndromes (3 papers). Albert Eid is often cited by papers focused on Cytomegalovirus and herpesvirus research (9 papers), Herpesvirus Infections and Treatments (6 papers) and Neurological Complications and Syndromes (3 papers). Albert Eid collaborates with scholars based in United States, Spain and Japan. Albert Eid's co-authors include Raymund R. Razonable, Robert A. Brown, Robin Patel, Paul J. Deziel, Mark Wilhelm, Ross Dierkhising, Walter K. Kremers, Rachel Pedersen, Mark J. Espy and Helen B. Viscount and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Transplantation.

In The Last Decade

Albert Eid

19 papers receiving 952 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Albert Eid United States 13 617 356 261 120 105 20 969
A.J. Eid United States 11 672 1.1× 245 0.7× 127 0.5× 102 0.8× 83 0.8× 14 773
Theresia Popow‐Kraupp Austria 20 801 1.3× 323 0.9× 114 0.4× 60 0.5× 135 1.3× 45 1.2k
Paula S. Dandliker United States 10 1.0k 1.7× 303 0.9× 364 1.4× 59 0.5× 149 1.4× 10 1.3k
Yuki Asano‐Mori Japan 18 433 0.7× 158 0.4× 251 1.0× 55 0.5× 171 1.6× 74 888
Cédric Hirzel Switzerland 16 338 0.5× 388 1.1× 162 0.6× 92 0.8× 100 1.0× 58 816
Carmen Díaz‐Pedroche Spain 13 402 0.7× 385 1.1× 161 0.6× 161 1.3× 48 0.5× 47 768
Dino Sgarabotto Italy 14 839 1.4× 347 1.0× 206 0.8× 124 1.0× 91 0.9× 45 1.2k
Nicolas C. Issa United States 18 551 0.9× 307 0.9× 183 0.7× 186 1.6× 146 1.4× 57 978
Luiz Sérgio Azevedo Brazil 10 298 0.5× 165 0.5× 78 0.3× 58 0.5× 44 0.4× 24 463
Stanley I. Martin United States 16 482 0.8× 310 0.9× 228 0.9× 204 1.7× 82 0.8× 27 996

Countries citing papers authored by Albert Eid

Since Specialization
Citations

This map shows the geographic impact of Albert Eid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Eid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Eid more than expected).

Fields of papers citing papers by Albert Eid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Eid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Eid. The network helps show where Albert Eid may publish in the future.

Co-authorship network of co-authors of Albert Eid

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Eid. A scholar is included among the top collaborators of Albert Eid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Eid. Albert Eid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dalia, Tarun, et al.. (2024). Heart transplantation from COVID‐positive donors with 6‐month follow‐up: A case series. Clinical Transplantation. 38(2). e15202–e15202.
2.
Foster, Keith, et al.. (2022). Pharmacologic Management of Mycobacterium chimaera Infections: A Primer for Clinicians. Open Forum Infectious Diseases. 9(7). ofac287–ofac287. 4 indexed citations
3.
Dandamudi, Raja, Naomi A. Drexler, Sridhar V. Basavaraju, et al.. (2021). Donor-derived Ehrlichiosis: 2 Clusters Following Solid Organ Transplantation. Clinical Infectious Diseases. 74(5). 918–923. 9 indexed citations
4.
Eid, Albert, et al.. (2019). Human parvovirus B19 in solid organ transplantation: Guidelines from the American society of transplantation infectious diseases community of practice. Clinical Transplantation. 33(9). e13535–e13535. 35 indexed citations
5.
Eid, Albert, et al.. (2015). CompartmentalizedHistoplasma capsulatumInfection of the Central Nervous System. SHILAP Revista de lepidopterología. 2015. 1–3. 8 indexed citations
7.
Eid, Albert & Elie F. Berbari. (2012). Osteomyelitis: review of pathophysiology, diagnostic modalities and therapeutic options.. PubMed. 60(1). 51–60. 12 indexed citations
8.
Brown, Robert A., et al.. (2010). R753Q Single-Nucleotide Polymorphism Impairs Toll-Like Receptor 2 Recognition of Hepatitis C Virus Core and Nonstructural 3 Proteins. Transplantation. 89(7). 811–815. 30 indexed citations
9.
Eid, Albert & Raymund R. Razonable. (2010). New Developments in the Management of Cytomegalovirus Infection after Solid Organ Transplantation. Drugs. 70(8). 965–981. 148 indexed citations
10.
Eid, Albert, Robert A. Brown, Brian D. Lahr, et al.. (2009). A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection. Transplant International. 23(5). 506–513. 41 indexed citations
11.
Eid, Albert, Paul J. Deziel, W.F. Marshall, et al.. (2009). The impact of invasive fungal diseases on survival after lung transplantation. Clinical Transplantation. 24(3). 341–348. 52 indexed citations
12.
Eid, Albert, Rachel Pedersen, Ross Dierkhising, et al.. (2007). Delayed-Onset Primary Cytomegalovirus Disease After Liver Transplantation. Liver Transplantation. 13(12). 1703–1709. 90 indexed citations
13.
Eid, Albert, et al.. (2007). Emergence of drug‐resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes. Clinical Transplantation. 22(2). 162–170. 135 indexed citations
14.
Eid, Albert, Robert A. Brown, Carlos V. Payá, & Raymund R. Razonable. (2007). Association Between Toll-Like Receptor Polymorphisms and the Outcome of Liver Transplantation for Chronic Hepatitis C Virus. Transplantation. 84(4). 511–516. 59 indexed citations
15.
Viscount, Helen B., Albert Eid, Mark J. Espy, et al.. (2007). Polyomavirus Polymerase Chain Reaction as a Surrogate Marker of Polyomavirus-Associated Nephropathy. Transplantation. 84(3). 340–345. 119 indexed citations
16.
Eid, Albert, Walter K. Kremers, Rachel Pedersen, et al.. (2007). Clinical Features and Outcomes of Delayed-onset Primary Cytomegalovirus Disease in Cardiac Transplant Recipients. The Journal of Heart and Lung Transplantation. 26(10). 1019–1024. 36 indexed citations
17.
Eid, Albert & Raymund R. Razonable. (2007). Valganciclovir for the treatment of cytomegalovirus retinitis in patients with AIDS. Expert Review of Ophthalmology. 2(3). 351–361. 5 indexed citations
18.
Eid, Albert & Raymund R. Razonable. (2007). Cytomegalovirus disease in solid organ transplant recipients: advances lead to new challenges and opportunities. Current Opinion in Organ Transplantation. 12(6). 610–617. 27 indexed citations
19.
Eid, Albert, Robert A. Brown, Robin Patel, & Raymund R. Razonable. (2006). Parvovirus B19 Infection after Transplantation: A Review of 98 Cases. Clinical Infectious Diseases. 43(1). 40–48. 154 indexed citations
20.
Eid, Albert & Robert Orenstein. (2006). Metabolic and morphologic complications of HIV infection.. PubMed. 54(2). 97–105. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026